Cargando…
Humanized virus-suppressing factor inhibits hepatitis B virus infection by targeting viral cell entry
Although nucleos(t)ide analogs and interferons suppress hepatitis B virus (HBV) replication, they must be taken continuously and have a low response rate. Therefore, therapeutics for HBV with novel modes of action are needed. Humanized virus-suppressing factor (hzVSF) is a monoclonal antibody agains...
Autores principales: | Miyakawa, Yu, Otsuka, Motoyuki, Sekiba, Kazuma, Funato, Kazuyoshi, Koike, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319007/ https://www.ncbi.nlm.nih.gov/pubmed/34345745 http://dx.doi.org/10.1016/j.heliyon.2021.e07586 |
Ejemplares similares
-
The fatty-acid amide hydrolase inhibitor URB597 inhibits MICA/B shedding
por: Sekiba, Kazuma, et al.
Publicado: (2020) -
Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018) -
DHX9 regulates production of hepatitis B virus-derived circular RNA and viral protein levels
por: Sekiba, Kazuma, et al.
Publicado: (2018) -
Cabozantinib inhibits HBV-RNA transcription by decreasing STAT3 binding to the enhancer region of cccDNA
por: Funato, Kazuyoshi, et al.
Publicado: (2023) -
Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction
por: Sekiba, Kazuma, et al.
Publicado: (2018)